Review abstract
Nature Neuroscience 10, 1116 - 1124 (2007)
Published online: 28 August 2007 | doi:10.1038/nn1944
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic
Kerry J Ressler1,2 & Helen S Mayberg1,3
Focus on Emotion and Disorders of Emotion
- Focus issue:
- September 2007 Volume 10, No 9
Abstract
Recent decades have witnessed tremendous advances in the neuroscience of emotion, learning and memory, and in animal models for understanding depression and anxiety. This review focuses on new rationally designed psychiatric treatments derived from preclinical human and animal studies. Nonpharmacological treatments that affect disrupted emotion circuits include vagal nerve stimulation, rapid transcranial magnetic stimulation and deep brain stimulation, all borrowed from neurological interventions that attempt to target known pathological foci. Other approaches include drugs that are given in relation to specific learning events to enhance or disrupt endogenous emotional learning processes. Imaging data suggest that common regions of brain activation are targeted with pharmacological and somatic treatments as well as with the emotional learning in psychotherapy. Although many of these approaches are experimental, the rapidly developing understanding of emotional circuit regulation is likely to provide exciting and powerful future treatments for debilitating mood and anxiety disorders.
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 954 Gatewood Drive, Atlanta, Georgia 30329, USA.
- Yerkes National Primate Research Center, Emory University School of Medicine, 954 Gatewood Drive, Atlanta, Georgia 30329, USA.
- Department of Neurology, Emory University School of Medicine, 954 Gatewood Drive, Atlanta, Georgia 30329, USA.
Correspondence to: Kerry J Ressler1,2 e-mail: kressle@emory.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Stressed and depressedNature Medicine News and Views (01 Feb 2005)
Anxiety: at the intersection of genes and experienceNature Neuroscience News and Views (01 Sep 1999)
RESEARCH
Systemic and Intra-Amygdala Administration of Glucocorticoid Agonist and Antagonist Modulate Extinction of Conditioned FearNeuropsychopharmacology Original Article
Systemic and Intra-Amygdala Administration of Glucocorticoid Agonist and Antagonist Modulate Extinction of Conditioned FearNeuropsychopharmacology Original Article
See all 49 matches for Research
